<DOC>
	<DOCNO>NCT02252185</DOCNO>
	<brief_summary>The primary objective study demonstrate efficacy safety Spine fusion system manufacture China inferior import product .</brief_summary>
	<brief_title>A Clinical Study Spine Fusion System Vertebral Body Fusion Surgery</brief_title>
	<detailed_description>This study prospective , multicenter , randomize , comparative , non-inferiority study compare change Japanese Orthopaedic Association Score baseline postoperative 24 week patient implant local make Spine Fusion System versus import product .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Spinal Cord Neoplasms</mesh_term>
	<mesh_term>Spinal Neoplasms</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>2070 year old , male female ; Subject diagnose disc degeneration disease , spondylolisthesis , spinal fracture , deformity ( degenerative deformity ) , spinal stenosis , spinal tumor , treat conservative treatment without relief get bad , suitable surgery accord clinic practice . Subject suitable candidate implant investigational product describe study protocol accord investigator 's assessment ; Patient , opinion Clinical Investigator , able understand clinical investigation willing available require study procedure study duration . Subject give voluntary , write informed consent participate clinical investigation authorize transfer his/her information study Sponsor . Patient local systemic infection . Patient one previous nonfusion spinal surgery involve level ( ) . Patient without spinal deformity require fusion 3 level . Has previously diagnose osteopenia , osteoporosis , osteomalacia degree spinal instrumentation would contraindicate Has presence active malignancy Has medical condition less 1 year life expectancy . Pregnancy woman lactation period . Is grossly obese , i.e . Body Mass Index≥40 . Has diagnosis , require postoperative medication treatment interfere fusion , steroid , chemotherapy , radiotherapy , growth factor ( 3 month ) , Nonsteroidal Antiinflammatory Drugs ( 3 month ) , etc . Has history endocrine metabolic disorder know affect osteogenesis ( e.g . uncontrolled Diabetes medication , renal osteodystrophy , osteogenesis imperfect ) Alcoholic ( take 40g/day , equal 100ml 50°Chinese liquor ) , smoke 40 cigarettes/day , Drug abuser ; Is currently participate another investigational drug device study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>